BRIMONIDINE TARTRATE, TIMOLOL MALEATE

BRIMONIDINE TARTRATE, TIMOLOL MALEATE was reported 6645 times

BRIMONIDINE TARTRATE, TIMOLOL MALEATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BENIGN VULVAL NEOPLASM 3 0.3750
1 CONJUNCTIVAL FOLLICLES 3 0.0938
2 PRODUCT DROPPER ISSUE 48 0.0610
3 INTRAOCULAR PRESSURE FLUCTUATION 12 0.0609
4 GLAUCOMA SURGERY 11 0.0430
5 ANTERIOR CHAMBER FIBRIN 5 0.0388
6 EYELID EXFOLIATION 24 0.0304
7 INTRAOCULAR PRESSURE DECREASED 14 0.0266
8 CORNEAL DEGENERATION 6 0.0248
9 ANGIOTENSIN CONVERTING ENZYME INCREASED 4 0.0244
10 OCULAR PEMPHIGOID 3 0.0240
11 INTRAOCULAR PRESSURE INCREASED 295 0.0231
12 SCLERAL HYPERAEMIA 15 0.0220
13 GROWTH OF EYELASHES 17 0.0215
14 EYE OPERATION COMPLICATION 3 0.0183
15 PERIORBITAL PAIN 15 0.0177
16 EYELID PAIN 32 0.0157
17 CONJUNCTIVITIS ALLERGIC 23 0.0155
18 FOREIGN BODY SENSATION IN EYES 95 0.0149
19 SCLERAL DISORDER 4 0.0148
20 CORNEAL DEPOSITS 11 0.0148
21 KERATIC PRECIPITATES 7 0.0147
22 OPEN ANGLE GLAUCOMA 9 0.0147
23 COUNTERFEIT DRUG ADMINISTERED 5 0.0145
24 INTRAOCULAR PRESSURE TEST ABNORMAL 10 0.0142
25 INTRAOCULAR LENS IMPLANT 7 0.0141
26 ERYTHEMA OF EYELID 76 0.0140
27 EYELID MARGIN CRUSTING 37 0.0128
28 EYELID IRRITATION 32 0.0127
29 EYE INFECTION VIRAL 4 0.0125
30 PRODUCT DELIVERY MECHANISM ISSUE 65 0.0121
31 DIABETIC RETINAL OEDEMA 6 0.0118
32 EYE ALLERGY 18 0.0116
33 PRODUCT CONTAINER ISSUE 99 0.0115
34 CORNEAL TRANSPLANT 9 0.0115
35 OCULAR HYPERAEMIA 544 0.0115
36 EYELIDS PRURITUS 35 0.0112
37 ANTERIOR CHAMBER CELL 8 0.0112
38 CORNEAL EROSION 6 0.0111
39 XANTHOPSIA 4 0.0108
40 VANCOMYCIN INFUSION REACTION 4 0.0106
41 CORNEAL DISORDER 23 0.0105
42 EYE INFECTION FUNGAL 4 0.0103
43 BLEPHARITIS 41 0.0102
44 EYE BURNS 6 0.0102
45 REACTION TO PRESERVATIVES 8 0.0098
46 GLARE 5 0.0097
47 HYPOTONY OF EYE 4 0.0095
48 INSTILLATION SITE ERYTHEMA 5 0.0095
49 CORNEAL OEDEMA 21 0.0094
50 EYE IRRITATION 532 0.0092
51 PACKAGING DESIGN ISSUE 3 0.0091
52 CHOROIDAL DETACHMENT 5 0.0090
53 MEIBOMIAN GLAND DYSFUNCTION 4 0.0088
54 POSTERIOR CAPSULE OPACIFICATION 3 0.0087
55 GLAUCOMA 165 0.0086
56 EYE PAIN 481 0.0085
57 EYE DISCHARGE 86 0.0083
58 EYELID DISORDER 18 0.0078
59 EYE PRURITUS 255 0.0076
60 EYELID SKIN DRYNESS 9 0.0074
61 SUPERFICIAL INJURY OF EYE 8 0.0073
62 EYE OPERATION 33 0.0072
63 EYE LASER SURGERY 4 0.0068
64 VITRECTOMY 4 0.0067
65 CORNEAL ABRASION 9 0.0066
66 INSTILLATION SITE PAIN 16 0.0065
67 CONJUNCTIVAL HYPERAEMIA 23 0.0064
68 FOREIGN BODY IN EYE 6 0.0063
69 BLEPHARAL PIGMENTATION 3 0.0059
70 RIGHT ATRIAL DILATATION 3 0.0059
71 LACRIMATION INCREASED 178 0.0059
72 CYSTOID MACULAR OEDEMA 11 0.0058
73 OCULAR DISCOMFORT 65 0.0058
74 OCULAR HYPERTENSION 11 0.0057
75 TOXIC ANTERIOR SEGMENT SYNDROME 6 0.0055
76 ANGLE CLOSURE GLAUCOMA 14 0.0055
77 DARK CIRCLES UNDER EYES 8 0.0054
78 EYE INFECTION BACTERIAL 3 0.0054
79 ABNORMAL SENSATION IN EYE 23 0.0053
80 EYE ULCER 3 0.0052
81 OPHTHALMIC HERPES SIMPLEX 3 0.0052
82 OPTIC NERVE INJURY 6 0.0052
83 PRODUCT DEPOSIT 8 0.0051
84 ANTERIOR CHAMBER INFLAMMATION 3 0.0050
85 EYE INFLAMMATION 48 0.0050
86 OPTIC NERVE DISORDER 8 0.0050
87 IRITIS 15 0.0049
88 RETINAL ISCHAEMIA 3 0.0049
89 BLINDNESS UNILATERAL 67 0.0047
90 SWELLING OF EYELID 29 0.0046
91 ENDOCRINE OPHTHALMOPATHY 4 0.0046
92 EYE INFECTION 52 0.0046
93 SCLERAL DISCOLOURATION 3 0.0046
94 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 3 0.0046
95 HERPES OPHTHALMIC 6 0.0045
96 CORNEAL OPACITY 6 0.0044
97 EYELID OEDEMA 51 0.0044
98 INCORRECT DOSE ADMINISTERED BY PRODUCT 7 0.0044
99 CONJUNCTIVAL HAEMORRHAGE 16 0.0042
100 EYE SWELLING 155 0.0042
101 IRIDOCYCLITIS 13 0.0041
102 PHOTOPHOBIA 76 0.0040
103 CHROMATOPSIA 3 0.0040
104 CONJUNCTIVAL OEDEMA 4 0.0039
105 ULCERATIVE KERATITIS 10 0.0036
106 OCULAR VASCULAR DISORDER 3 0.0036
107 ENDOPHTHALMITIS 20 0.0033
108 UVEITIS 45 0.0033
109 VISUAL ACUITY REDUCED 109 0.0033
110 PUNCTATE KERATITIS 3 0.0033
111 ADENOCARCINOMA GASTRIC 3 0.0032
112 EYELID RASH 3 0.0031
113 MACULAR HOLE 4 0.0030
114 REBOUND ACID HYPERSECRETION 9 0.0030
115 CALCULUS BLADDER 4 0.0029
116 CORONAVIRUS TEST POSITIVE 3 0.0029
117 RENAL MASS 6 0.0029
118 ASTHENOPIA 16 0.0029
119 STARING 7 0.0029
120 PRODUCT CONTAINER SEAL ISSUE 5 0.0029
121 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0028
122 OPHTHALMIC HERPES ZOSTER 5 0.0028
123 DRY EYE 138 0.0028
124 INSTILLATION SITE REACTION 3 0.0028
125 ESSENTIAL HYPERTENSION 5 0.0027
126 METAMORPHOPSIA 5 0.0027
127 CATARACT 161 0.0027
128 RETINAL DISORDER 7 0.0027
129 PHOTOPSIA 17 0.0027
130 HALO VISION 3 0.0027
131 EYE INJURY 8 0.0026
132 PARAINFLUENZAE VIRUS INFECTION 4 0.0026
133 ORAL MUCOSAL ERUPTION 4 0.0026
134 PULMONARY FUNCTION TEST ABNORMAL 4 0.0026
135 VITREOUS FLOATERS 25 0.0025
136 INSTILLATION SITE IRRITATION 3 0.0025
137 NIGHT BLINDNESS 4 0.0025
138 VISION BLURRED 341 0.0025
139 BLADDER PROLAPSE 3 0.0025
140 CONJUNCTIVITIS 45 0.0024
141 HYPERPARATHYROIDISM SECONDARY 6 0.0024
142 RETINAL ARTERY OCCLUSION 6 0.0024
143 CATARACT OPERATION 14 0.0024
144 LEFT ATRIAL DILATATION 3 0.0024
145 VISUAL FIELD DEFECT 17 0.0024
146 EYE DISORDER 77 0.0023
147 INCORRECT STORAGE OF DRUG 4 0.0023
148 KERATITIS 7 0.0023
149 RETINAL DETACHMENT 21 0.0023
150 SKIN HYPOPIGMENTATION 4 0.0023
151 PRODUCT LOT NUMBER ISSUE 5 0.0023
152 VITRITIS 4 0.0022
153 PUPILLARY REFLEX IMPAIRED 4 0.0022
154 NEPHROGENIC ANAEMIA 10 0.0022
155 AUDITORY DISORDER 3 0.0021
156 MYOPIA 5 0.0021
157 BLINDNESS TRANSIENT 15 0.0020
158 EXCESSIVE EYE BLINKING 3 0.0020
159 RETINAL TEAR 5 0.0020
160 EYE HAEMORRHAGE 27 0.0020
161 FACIAL PAIN 17 0.0019
162 EYELID PTOSIS 19 0.0019
163 BLINDNESS 76 0.0019
164 MIGRAINE WITH AURA 5 0.0018
165 VITREOUS HAEMORRHAGE 5 0.0018
166 CONTRAINDICATED PRODUCT PRESCRIBED 3 0.0018
167 PRODUCT USE COMPLAINT 28 0.0018
168 DIABETIC RETINOPATHY 6 0.0018
169 MACULAR DEGENERATION 21 0.0018
170 PRODUCT COLOUR ISSUE 9 0.0018
171 MEDICAL DEVICE REMOVAL 3 0.0017
172 POOR QUALITY PRODUCT ADMINISTERED 18 0.0017
173 VISUAL IMPAIRMENT 211 0.0017
174 FEAR OF DISEASE 3 0.0017
175 RETINAL HAEMORRHAGE 12 0.0017
176 NASAL OEDEMA 3 0.0017
177 METASTATIC RENAL CELL CARCINOMA 3 0.0016
178 CATHETER PLACEMENT 3 0.0016
179 MACULAR OEDEMA 9 0.0016
180 NASAL DRYNESS 10 0.0016
181 PERIORBITAL SWELLING 9 0.0016
182 PARANASAL SINUS DISCOMFORT 6 0.0016
183 HEPATIC MASS 3 0.0016
184 ACCIDENTAL EXPOSURE TO PRODUCT 158 0.0015
185 HYPERAEMIA 3 0.0015
186 SKIN HYPERPIGMENTATION 13 0.0015
187 TEMPOROMANDIBULAR JOINT SYNDROME 4 0.0015
188 TRICHORRHEXIS 4 0.0014
189 DRY MOUTH 116 0.0014
190 EAR SWELLING 3 0.0014
191 RENAL NEOPLASM 3 0.0014
192 HEART RATE DECREASED 49 0.0014
193 RETINAL VEIN OCCLUSION 4 0.0014
194 SPUTUM INCREASED 3 0.0014
195 PRODUCT PACKAGING ISSUE 13 0.0014
196 HAEMORRHAGIC ANAEMIA 6 0.0014
197 PRODUCT STORAGE ERROR 119 0.0014
198 CALCINOSIS 3 0.0013
199 READING DISORDER 3 0.0013
200 PRODUCT SIZE ISSUE 7 0.0013
201 PRODUCT DOSE OMISSION 85 0.0013
202 PRODUCT RESIDUE PRESENT 7 0.0013
203 PRODUCT PHYSICAL CONSISTENCY ISSUE 7 0.0013
204 PRODUCT LEAKAGE 7 0.0012
205 VITAMIN B12 DEFICIENCY 5 0.0012
206 PROSTATIC SPECIFIC ANTIGEN INCREASED 17 0.0012
207 DEAFNESS NEUROSENSORY 4 0.0012
208 BODY HEIGHT DECREASED 13 0.0012
209 HALLUCINATIONS, MIXED 5 0.0012
210 EXCORIATION 3 0.0012
211 BLOOD PRESSURE DIASTOLIC ABNORMAL 3 0.0012
212 PRODUCT DISPENSING ISSUE 5 0.0012
213 ACTINIC KERATOSIS 3 0.0012
214 OCULAR ICTERUS 5 0.0012
215 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 81 0.0011
216 PRODUCT ADMINISTRATION ERROR 23 0.0011
217 NASAL DISORDER 3 0.0011
218 MACULOPATHY 4 0.0011
219 BLOOD POTASSIUM ABNORMAL 3 0.0011
220 PRE-EXISTING CONDITION IMPROVED 7 0.0011
221 ABDOMINAL RIGIDITY 3 0.0011
222 MYDRIASIS 14 0.0011
223 HYPERKERATOSIS 6 0.0011
224 SLUGGISHNESS 11 0.0011
225 RETINOPATHY 4 0.0011
226 ACUTE PULMONARY OEDEMA 6 0.0011
227 BRADYCARDIA 56 0.0011
228 IMPAIRED DRIVING ABILITY 12 0.0011
229 HAEMOTHORAX 3 0.0010
230 MADAROSIS 12 0.0010
231 CONCUSSION 8 0.0010
232 HEART RATE IRREGULAR 23 0.0010
233 DROOLING 7 0.0010
234 HYPERVOLAEMIA 5 0.0010
235 IDIOPATHIC PULMONARY FIBROSIS 4 0.0010
236 NASAL DISCOMFORT 8 0.0010
237 METABOLIC ENCEPHALOPATHY 3 0.0010
238 END STAGE RENAL DISEASE 18 0.0010
239 SMALL INTESTINAL OBSTRUCTION 12 0.0010
240 DIASTOLIC DYSFUNCTION 3 0.0010
241 DEVICE USE ISSUE 17 0.0010
242 SCAB 11 0.0010
243 PERIORBITAL OEDEMA 5 0.0010
244 BLOOD BLISTER 3 0.0010
245 LIQUID PRODUCT PHYSICAL ISSUE 7 0.0010
246 BLOOD PRESSURE DECREASED 62 0.0009
247 SINUS BRADYCARDIA 9 0.0009
248 HORDEOLUM 4 0.0009
249 VITAMIN D DEFICIENCY 9 0.0009
250 POSTURE ABNORMAL 3 0.0009
251 HEPATIC NEOPLASM 3 0.0009
252 ONYCHOMYCOSIS 4 0.0009
253 NONSPECIFIC REACTION 5 0.0009
254 ANAL INCONTINENCE 8 0.0009
255 ECCHYMOSIS 6 0.0009
256 BLOOD PRESSURE FLUCTUATION 21 0.0009
257 BLOOD THYROID STIMULATING HORMONE INCREASED 8 0.0009
258 HAIR GROWTH ABNORMAL 6 0.0009
259 TIBIA FRACTURE 4 0.0009
260 PRODUCT CONTAMINATION 3 0.0008
261 EXPIRED PRODUCT ADMINISTERED 28 0.0008
262 HYPERSENSITIVITY 156 0.0008
263 CARDIAC PACEMAKER INSERTION 5 0.0008
264 SPONDYLITIS 3 0.0008
265 CHRONIC KIDNEY DISEASE 62 0.0008
266 DIPLOPIA 21 0.0008
267 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
268 ANEURYSM 4 0.0008
269 INFUSION SITE EXTRAVASATION 5 0.0008
270 BONE DENSITY ABNORMAL 3 0.0008
271 PERIPHERAL COLDNESS 11 0.0008
272 PRODUCT COMPLAINT 20 0.0008
273 DERMATITIS CONTACT 9 0.0008
274 RHINORRHOEA 51 0.0008
275 DRY THROAT 8 0.0008
276 WOUND 22 0.0008
277 PRODUCT TEMPERATURE EXCURSION ISSUE 4 0.0008
278 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
279 POOR QUALITY DRUG ADMINISTERED 5 0.0008
280 PARTIAL SEIZURES 4 0.0008
281 OESOPHAGEAL PAIN 3 0.0008
282 SUSPECTED COUNTERFEIT PRODUCT 3 0.0008
283 SNEEZING 17 0.0008
284 PRODUCT FORMULATION ISSUE 5 0.0008
285 SINUS DISORDER 15 0.0008
286 TERMINAL STATE 5 0.0007
287 FULL BLOOD COUNT DECREASED 15 0.0007
288 STRESS FRACTURE 4 0.0007
289 SPUTUM DISCOLOURED 7 0.0007
290 PRODUCT LABEL ISSUE 5 0.0007
291 PALLOR 20 0.0007
292 HEAD DISCOMFORT 13 0.0007
293 SPINAL STENOSIS 3 0.0007
294 OSTEOPENIA 11 0.0007
295 MUSCLE INJURY 6 0.0007
296 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
297 DIZZINESS POSTURAL 7 0.0007
298 LARGE INTESTINE POLYP 5 0.0007
299 BALANCE DISORDER 62 0.0007
300 HIP FRACTURE 23 0.0007
301 DEFAECATION URGENCY 5 0.0007
302 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
303 PERONEAL NERVE PALSY 4 0.0007
304 ABSCESS LIMB 3 0.0007
305 HYPOTONIA 7 0.0007
306 RESPIRATORY TRACT CONGESTION 11 0.0007
307 MUSCULAR WEAKNESS 78 0.0007
308 INITIAL INSOMNIA 7 0.0007
309 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
310 TOOTH DISORDER 15 0.0007
311 SINUS HEADACHE 4 0.0007
312 SUNBURN 5 0.0007
313 WEIGHT FLUCTUATION 7 0.0007
314 TYPE 1 DIABETES MELLITUS 4 0.0007
315 DRUG ADMINISTERED AT INAPPROPRIATE SITE 7 0.0007
316 FULL BLOOD COUNT ABNORMAL 7 0.0007
317 INGUINAL HERNIA 4 0.0007
318 EXOSTOSIS 6 0.0007
319 EAR DISORDER 3 0.0007
320 HYPERCALCAEMIA 8 0.0006
321 PERFORMANCE STATUS DECREASED 3 0.0006
322 SECRETION DISCHARGE 8 0.0006
323 SKIN TIGHTNESS 3 0.0006
324 LYMPHOPENIA 9 0.0006
325 SEASONAL ALLERGY 9 0.0006
326 RED BLOOD CELL COUNT DECREASED 18 0.0006
327 MEDICATION RESIDUE PRESENT 3 0.0006
328 HYPERSOMNIA 18 0.0006
329 POLLAKIURIA 26 0.0006
330 MIOSIS 5 0.0006
331 STENT PLACEMENT 5 0.0006
332 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
333 SKIN FISSURES 12 0.0006
334 INCORRECT DOSAGE ADMINISTERED 3 0.0006
335 MICTURITION URGENCY 7 0.0006
336 HALLUCINATION 46 0.0006
337 BODY TEMPERATURE DECREASED 6 0.0006
338 SPRUE-LIKE ENTEROPATHY 3 0.0006
339 TOOTH INFECTION 8 0.0006
340 SOMNOLENCE 122 0.0006
341 CARDIAC FAILURE ACUTE 4 0.0006
342 INCORRECT DOSE ADMINISTERED 137 0.0006
343 SKIN MASS 4 0.0006
344 FALL 199 0.0006
345 CORONARY ARTERY STENOSIS 3 0.0006
346 PRODUCT SOLUBILITY ABNORMAL 3 0.0006
347 DYSLIPIDAEMIA 3 0.0006
348 PHLEBITIS 3 0.0006
349 EAR DISCOMFORT 6 0.0006
350 ONYCHOCLASIS 4 0.0006
351 FEELING COLD 16 0.0006
352 CARPAL TUNNEL SYNDROME 8 0.0006
353 RIGHT VENTRICULAR FAILURE 4 0.0006
354 BLOOD CALCIUM INCREASED 5 0.0006
355 DIVERTICULUM 4 0.0006
356 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
357 NEUTROPENIC SEPSIS 4 0.0006
358 FREQUENT BOWEL MOVEMENTS 15 0.0006
359 ATRIAL FIBRILLATION 54 0.0006
360 PRODUCT DISPENSING ERROR 12 0.0006
361 SYNCOPE 55 0.0005
362 HYPOTENSION 110 0.0005
363 HYPOPHAGIA 14 0.0005
364 MOUTH HAEMORRHAGE 4 0.0005
365 PRODUCT PHYSICAL ISSUE 11 0.0005
366 DEAFNESS UNILATERAL 3 0.0005
367 PROSTATIC DISORDER 3 0.0005
368 IRON DEFICIENCY ANAEMIA 5 0.0005
369 DIZZINESS 270 0.0005
370 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
371 DRUG DOSE OMISSION 89 0.0005
372 MULTIPLE USE OF SINGLE-USE PRODUCT 3 0.0005
373 BLOOD SODIUM DECREASED 10 0.0005
374 AORTIC ANEURYSM 4 0.0005
375 MUSCULOSKELETAL DISORDER 10 0.0005
376 DERMATITIS 11 0.0005
377 SLEEP APNOEA SYNDROME 10 0.0005
378 TINNITUS 24 0.0005
379 HALLUCINATION, VISUAL 11 0.0005
380 RALES 3 0.0005
381 PRODUCT QUALITY ISSUE 70 0.0005
382 BURNING SENSATION 36 0.0005
383 HOSPICE CARE 5 0.0005
384 HEAD INJURY 16 0.0005
385 BLADDER DISORDER 5 0.0005
386 ODYNOPHAGIA 3 0.0005
387 RASH GENERALISED 13 0.0005
388 SCIATICA 8 0.0005
389 DEMENTIA 14 0.0005
390 MASS 7 0.0005
391 WRIST FRACTURE 6 0.0005
392 HEARING IMPAIRED 3 0.0005
393 OVARIAN CYST 5 0.0005
394 SENSORY DISTURBANCE 8 0.0005
395 TOOTHACHE 9 0.0005
396 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
397 PLATELET COUNT ABNORMAL 3 0.0005
398 DYSPHONIA 29 0.0005
399 DRUG EFFECT INCOMPLETE 18 0.0005
400 ADRENAL INSUFFICIENCY 6 0.0005
401 NOCTURIA 6 0.0005
402 FATIGUE 383 0.0005
403 PRODUCT DOSE OMISSION ISSUE 144 0.0005
404 ABNORMAL FAECES 4 0.0005
405 SINUSITIS 50 0.0005
406 HYPERAESTHESIA 4 0.0005
407 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
408 SKIN EXFOLIATION 41 0.0005
409 ASTHENIA 182 0.0005
410 SKIN DISCOLOURATION 22 0.0005
411 PRODUCT ODOUR ABNORMAL 5 0.0005
412 SENSATION OF FOREIGN BODY 4 0.0005
413 TRANSIENT ISCHAEMIC ATTACK 16 0.0005
414 MOOD SWINGS 15 0.0005
415 PULMONARY MASS 7 0.0005
416 LETHARGY 27 0.0005
417 ACUTE RESPIRATORY FAILURE 9 0.0005
418 ERYTHEMA 96 0.0005
419 HAEMOGLOBIN ABNORMAL 3 0.0005
420 BLOOD POTASSIUM DECREASED 14 0.0005
421 CARDIAC FLUTTER 3 0.0005
422 CONFUSIONAL STATE 75 0.0005
423 BLOOD MAGNESIUM DECREASED 4 0.0005
424 PRURITUS GENERALISED 10 0.0005
425 HAEMORRHOIDS 9 0.0005
426 FAECES DISCOLOURED 10 0.0005
427 PERIPHERAL SWELLING 71 0.0005
428 VERTIGO 28 0.0005
429 SOMNAMBULISM 3 0.0005
430 THYROID DISORDER 7 0.0005
431 HAEMATOCRIT DECREASED 9 0.0005
432 ANKLE FRACTURE 7 0.0005
433 RED BLOOD CELL SEDIMENTATION RATE INCREASED 5 0.0005
434 DIABETES MELLITUS INADEQUATE CONTROL 8 0.0005
435 UPPER LIMB FRACTURE 9 0.0005
436 ARTHROPATHY 25 0.0004
437 WRONG DRUG ADMINISTERED 4 0.0004
438 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
439 QUALITY OF LIFE DECREASED 6 0.0004
440 TREATMENT FAILURE 37 0.0004
441 THERAPEUTIC RESPONSE UNEXPECTED 20 0.0004
442 CONSTIPATION 97 0.0004
443 HYPERTENSION 94 0.0004
444 LIP DRY 4 0.0004
445 OPTIC NEURITIS 4 0.0004
446 CYSTITIS 14 0.0004
447 BLOOD TESTOSTERONE DECREASED 3 0.0004
448 INFARCTION 3 0.0004
449 ACCIDENTAL OVERDOSE 16 0.0004
450 INCREASED TENDENCY TO BRUISE 4 0.0004
451 UROSEPSIS 4 0.0004
452 DIVERTICULITIS 12 0.0004
453 BLOOD POTASSIUM INCREASED 7 0.0004
454 AMNESIA 28 0.0004
455 CORONARY ARTERY DISEASE 13 0.0004
456 HYPERKALAEMIA 15 0.0004
457 CHOLELITHIASIS 14 0.0004
458 BLOOD PRESSURE INCREASED 65 0.0004
459 STAPHYLOCOCCAL INFECTION 14 0.0004
460 LEUKAEMIA 4 0.0004
461 COVID-19 PNEUMONIA 5 0.0004
462 EATING DISORDER 9 0.0004
463 INTENTIONAL PRODUCT MISUSE 37 0.0004
464 SPINAL DISORDER 4 0.0004
465 URINARY TRACT INFECTION 72 0.0004
466 BACTERAEMIA 5 0.0004
467 BRONCHOSPASM 6 0.0004
468 RECALLED PRODUCT ADMINISTERED 4 0.0004
469 HYPOACUSIS 18 0.0004
470 WEIGHT DECREASED 116 0.0004
471 SKIN IRRITATION 19 0.0004
472 DERMATITIS BULLOUS 3 0.0004
473 HYPERCHOLESTEROLAEMIA 4 0.0004
474 ATELECTASIS 4 0.0004
475 DECREASED APPETITE 96 0.0004
476 GAIT DISTURBANCE 79 0.0004
477 THERAPEUTIC RESPONSE DECREASED 25 0.0004
478 NECK PAIN 23 0.0004
479 EAR PAIN 8 0.0004
480 CHEST DISCOMFORT 42 0.0004
481 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
482 THERAPY CHANGE 4 0.0004
483 MUSCULOSKELETAL DISCOMFORT 7 0.0004
484 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
485 FLATULENCE 23 0.0004
486 MOVEMENT DISORDER 13 0.0004
487 NERVOUSNESS 21 0.0004
488 SWELLING FACE 26 0.0004
489 DISCOMFORT 24 0.0004
490 NEPHROLITHIASIS 18 0.0004
491 HEADACHE 246 0.0004
492 DRUG ADMINISTRATION ERROR 12 0.0004
493 GOUT 7 0.0004
494 DRY SKIN 52 0.0004
495 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 70 0.0004
496 EPISTAXIS 29 0.0004
497 TEMPERATURE INTOLERANCE 4 0.0004
498 OSTEOMYELITIS 7 0.0004
499 POOR VENOUS ACCESS 4 0.0004
500 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
501 INTENTIONAL DOSE OMISSION 11 0.0004
502 PELVIC FRACTURE 3 0.0004
503 THERAPY PARTIAL RESPONDER 6 0.0004
504 ANGINA PECTORIS 11 0.0004
505 TENDERNESS 4 0.0004
506 NODULE 5 0.0004
507 MULTIPLE ALLERGIES 3 0.0004
508 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
509 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
510 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
511 FOLLICULITIS 4 0.0004
512 INCORRECT PRODUCT STORAGE 5 0.0004
513 SCRATCH 4 0.0004
514 DISORIENTATION 15 0.0004
515 NEUROPATHY PERIPHERAL 36 0.0004
516 RENAL CYST 3 0.0004
517 OEDEMA PERIPHERAL 46 0.0004
518 DYSSTASIA 11 0.0004
519 RENAL FAILURE 50 0.0004
520 ATRIAL FLUTTER 3 0.0004
521 MOBILITY DECREASED 27 0.0004
522 PALPITATIONS 44 0.0004
523 NO ADVERSE EVENT 68 0.0004
524 RETCHING 8 0.0004
525 MIDDLE INSOMNIA 7 0.0004
526 GASTROOESOPHAGEAL REFLUX DISEASE 30 0.0004
527 ACUTE KIDNEY INJURY 57 0.0004
528 RHINITIS 3 0.0004
529 SKIN CANCER 8 0.0004
530 URINARY INCONTINENCE 11 0.0004
531 MUSCLE DISORDER 3 0.0004
532 RENAL INJURY 11 0.0004
533 EXTRA DOSE ADMINISTERED 15 0.0004
534 SINUS CONGESTION 5 0.0004
535 RASH PRURITIC 20 0.0004
536 POST PROCEDURAL INFECTION 3 0.0004
537 PULMONARY THROMBOSIS 4 0.0004
538 POLYURIA 3 0.0004
539 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 74 0.0004
540 LOWER LIMB FRACTURE 7 0.0004
541 MEMORY IMPAIRMENT 50 0.0004
542 DYSGEUSIA 27 0.0004
543 SPEECH DISORDER 19 0.0004
544 HERNIA 7 0.0004
545 ORAL DISCOMFORT 5 0.0004
546 SKIN DISORDER 12 0.0004
547 NERVE INJURY 4 0.0004
548 PRURITUS 138 0.0004
549 ARRHYTHMIA 17 0.0004
550 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
551 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
552 THROAT IRRITATION 16 0.0004
553 FISTULA 4 0.0004
554 BLOOD CALCIUM DECREASED 4 0.0004
555 DEVICE OCCLUSION 5 0.0004
556 DISABILITY 7 0.0004
557 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
558 MITRAL VALVE INCOMPETENCE 4 0.0004
559 CONTUSION 34 0.0004
560 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
561 COUGH 99 0.0004
562 BRONCHITIS 26 0.0004
563 PSEUDOMONAS INFECTION 3 0.0003
564 SPINAL FRACTURE 7 0.0003
565 SUBDURAL HAEMATOMA 5 0.0003
566 INFLAMMATION 18 0.0003
567 CARDIOGENIC SHOCK 5 0.0003
568 IMPAIRED QUALITY OF LIFE 5 0.0003
569 TREATMENT NONCOMPLIANCE 19 0.0003
570 HYSTERECTOMY 3 0.0003
571 ABDOMINAL DISCOMFORT 58 0.0003
572 RESPIRATORY TRACT INFECTION 9 0.0003
573 INSOMNIA 92 0.0003
574 TASTE DISORDER 7 0.0003
575 HOT FLUSH 26 0.0003
576 ELECTROLYTE IMBALANCE 4 0.0003
577 ARTHRITIS 27 0.0003
578 NAIL DISORDER 3 0.0003
579 APATHY 5 0.0003
580 BONE PAIN 20 0.0003
581 SPINAL PAIN 4 0.0003
582 DIABETES MELLITUS 26 0.0003
583 HAEMOGLOBIN DECREASED 35 0.0003
584 RIB FRACTURE 7 0.0003
585 OFF LABEL USE 297 0.0003
586 EAR INFECTION 9 0.0003
587 RESPIRATORY RATE INCREASED 3 0.0003
588 BLOOD IRON DECREASED 4 0.0003
589 CARDIAC FAILURE CONGESTIVE 27 0.0003
590 THERAPY INTERRUPTED 24 0.0003
591 PULMONARY OEDEMA 15 0.0003
592 HAEMORRHAGE INTRACRANIAL 5 0.0003
593 DIARRHOEA 215 0.0003
594 LIMB INJURY 9 0.0003
595 HERPES ZOSTER 19 0.0003
596 ANAEMIA 63 0.0003
597 NEURALGIA 8 0.0003
598 INFLUENZA LIKE ILLNESS 27 0.0003
599 JOINT INJURY 7 0.0003
600 HYPOAESTHESIA 49 0.0003
601 IRRITABLE BOWEL SYNDROME 7 0.0003
602 NERVE COMPRESSION 3 0.0003
603 BLOOD GLUCOSE ABNORMAL 6 0.0003
604 SPINAL OPERATION 4 0.0003
605 OROPHARYNGEAL PAIN 30 0.0003
606 PRODUCT DISTRIBUTION ISSUE 3 0.0003
607 NASAL CONGESTION 19 0.0003
608 HAEMOPTYSIS 9 0.0003
609 RENAL DISORDER 15 0.0003
610 HAIR COLOUR CHANGES 4 0.0003
611 FEELING ABNORMAL 77 0.0003
612 NEPHROPATHY 3 0.0003
613 MUSCULOSKELETAL STIFFNESS 28 0.0003
614 BRAIN FOG 5 0.0003
615 ARTERIOSCLEROSIS 3 0.0003
616 SQUAMOUS CELL CARCINOMA 3 0.0003
617 FRACTURE 6 0.0003
618 GLYCOSYLATED HAEMOGLOBIN INCREASED 8 0.0003
619 FOOT FRACTURE 6 0.0003
620 MUSCLE ATROPHY 4 0.0003
621 ULCER 5 0.0003
622 OEDEMA 17 0.0003
623 HYPOTHYROIDISM 10 0.0003
624 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0003
625 NIGHT SWEATS 10 0.0003
626 ERUCTATION 6 0.0003
627 SKIN ULCER 8 0.0003
628 HYPOGLYCAEMIA 15 0.0003
629 PLATELET COUNT INCREASED 4 0.0003
630 ABDOMINAL DISTENSION 32 0.0003
631 KIDNEY INFECTION 6 0.0003
632 MUSCULOSKELETAL PAIN 16 0.0003
633 LABORATORY TEST ABNORMAL 9 0.0003
634 JOINT STIFFNESS 8 0.0003
635 PNEUMONIA 97 0.0003
636 SWELLING 28 0.0003
637 PARAESTHESIA 47 0.0003
638 THROMBOSIS 24 0.0003
639 EMPHYSEMA 3 0.0003
640 CANDIDA INFECTION 5 0.0003
641 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
642 THROAT TIGHTNESS 8 0.0003
643 PRODUCT TASTE ABNORMAL 4 0.0003
644 PAIN IN EXTREMITY 87 0.0003
645 NEUTROPHIL COUNT INCREASED 3 0.0003
646 NASOPHARYNGITIS 54 0.0003
647 RASH ERYTHEMATOUS 14 0.0003
648 SKIN LESION 8 0.0003
649 GYNAECOMASTIA 9 0.0003
650 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
651 LOSS OF CONSCIOUSNESS 37 0.0003
652 BACK PAIN 67 0.0003
653 SWOLLEN TONGUE 9 0.0003
654 PRESYNCOPE 7 0.0003
655 APHONIA 4 0.0003
656 CHEST PAIN 53 0.0003
657 METASTASES TO LIVER 5 0.0003
658 INCORRECT DRUG ADMINISTRATION DURATION 8 0.0003
659 DYSPNOEA 161 0.0003
660 INCONTINENCE 3 0.0003
661 HYPOKALAEMIA 13 0.0003
662 PLATELET COUNT DECREASED 30 0.0003
663 AGEUSIA 7 0.0003
664 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
665 THIRST 5 0.0003
666 DISEASE PROGRESSION 33 0.0003
667 CEREBROVASCULAR ACCIDENT 47 0.0003
668 PARAESTHESIA ORAL 4 0.0003
669 DRUG INEFFECTIVE 365 0.0003
670 ABDOMINAL PAIN UPPER 57 0.0003
671 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
672 BLOOD GLUCOSE INCREASED 52 0.0003
673 SKIN LACERATION 3 0.0003
674 WRONG TECHNIQUE IN DRUG USAGE PROCESS 10 0.0003
675 ALOPECIA 54 0.0003
676 FLUID OVERLOAD 4 0.0003
677 OESOPHAGITIS 3 0.0003
678 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
679 ASPIRATION 3 0.0003
680 MUSCLE SPASMS 50 0.0003
681 TOOTH FRACTURE 3 0.0003
682 UNRESPONSIVE TO STIMULI 7 0.0003
683 DENTAL CARIES 3 0.0003
684 RASH MACULO-PAPULAR 6 0.0003
685 GAIT INABILITY 9 0.0003
686 THINKING ABNORMAL 5 0.0003
687 BACTERIAL INFECTION 5 0.0003
688 DEAFNESS 7 0.0003
689 RASH PAPULAR 6 0.0003
690 SKIN INFECTION 3 0.0003
691 CARDIAC DISORDER 25 0.0003
692 BLISTER 15 0.0003
693 FLUSHING 27 0.0003
694 HYPOAESTHESIA ORAL 4 0.0003
695 JOINT SWELLING 32 0.0003
696 MALAISE 116 0.0003
697 CHILLS 31 0.0003
698 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
699 DEPRESSION 60 0.0003
700 DYSPHAGIA 25 0.0003
701 CHOLECYSTECTOMY 3 0.0003
702 HIP ARTHROPLASTY 4 0.0003
703 PRODUCT USE ISSUE 49 0.0003
704 BLOOD CREATININE INCREASED 17 0.0003
705 DRUG PRESCRIBING ERROR 5 0.0003
706 PHARYNGEAL OEDEMA 4 0.0003
707 OSTEOARTHRITIS 11 0.0003
708 NEOPLASM PROGRESSION 9 0.0003
709 MYALGIA 44 0.0003
710 MUSCULOSKELETAL CHEST PAIN 4 0.0003
711 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6 0.0003
712 MOOD ALTERED 7 0.0003
713 CONDITION AGGRAVATED 78 0.0003
714 COVID-19 45 0.0003
715 CHOKING 5 0.0003
716 SURGERY 15 0.0003
717 WEIGHT INCREASED 57 0.0003
718 WHEEZING 15 0.0003
719 ABNORMAL BEHAVIOUR 10 0.0003
720 HEART RATE INCREASED 25 0.0003
721 PRODUCTIVE COUGH 12 0.0003
722 INFLUENZA 28 0.0003
723 HYPERLIPIDAEMIA 3 0.0003
724 ABSCESS 4 0.0003
725 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
726 WHITE BLOOD CELL COUNT DECREASED 27 0.0002
727 RASH 108 0.0002
728 MENTAL IMPAIRMENT 6 0.0002
729 HYPERGLYCAEMIA 9 0.0002
730 FEEDING DISORDER 5 0.0002
731 BACK DISORDER 4 0.0002
732 CARDIOMEGALY 3 0.0002
733 ABASIA 6 0.0002
734 OSTEONECROSIS OF JAW 6 0.0002
735 GENERAL PHYSICAL HEALTH DETERIORATION 28 0.0002
736 PHARYNGITIS 3 0.0002
737 CYST 3 0.0002
738 PNEUMONIA ASPIRATION 6 0.0002
739 COAGULOPATHY 4 0.0002
740 FUNGAL INFECTION 8 0.0002
741 GASTROINTESTINAL HAEMORRHAGE 20 0.0002
742 INTESTINAL OBSTRUCTION 9 0.0002
743 CELLULITIS 12 0.0002
744 DRUG INTOLERANCE 23 0.0002
745 TYPE 2 DIABETES MELLITUS 8 0.0002
746 COLITIS 9 0.0002
747 ABDOMINAL PAIN LOWER 6 0.0002
748 FACE OEDEMA 4 0.0002
749 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
750 HEPATITIS 6 0.0002
751 MEDICATION ERROR 13 0.0002
752 GASTRIC DISORDER 8 0.0002
753 INFUSION SITE PAIN 3 0.0002
754 PAIN 143 0.0002
755 POOR QUALITY SLEEP 5 0.0002
756 EXPOSURE VIA SKIN CONTACT 6 0.0002
757 PLASMA CELL MYELOMA 9 0.0002
758 ORTHOSTATIC HYPOTENSION 4 0.0002
759 MYOCARDIAL INFARCTION 40 0.0002
760 ORAL CANDIDIASIS 3 0.0002
761 ANKYLOSING SPONDYLITIS 3 0.0002
762 MELAENA 5 0.0002
763 SARS-COV-2 TEST POSITIVE 3 0.0002
764 SLEEP DISORDER 16 0.0002
765 LIMB DISCOMFORT 7 0.0002
766 NAUSEA 179 0.0002
767 ARTHRALGIA 94 0.0002
768 FEMUR FRACTURE 7 0.0002
769 HYPERHIDROSIS 29 0.0002
770 DEHYDRATION 30 0.0002
771 MALIGNANT NEOPLASM PROGRESSION 23 0.0002
772 HAIR TEXTURE ABNORMAL 3 0.0002
773 ISCHAEMIC STROKE 4 0.0002
774 CEREBRAL HAEMORRHAGE 8 0.0002
775 GLOSSODYNIA 5 0.0002
776 GASTROINTESTINAL DISORDER 20 0.0002
777 RESTLESS LEGS SYNDROME 4 0.0002
778 GINGIVAL BLEEDING 3 0.0002
779 PRODUCT AVAILABILITY ISSUE 5 0.0002
780 DEATH 189 0.0002
781 OSTEOPOROSIS 9 0.0002
782 CORONARY ARTERY OCCLUSION 3 0.0002
783 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4 0.0002
784 RESPIRATORY DISTRESS 6 0.0002
785 PERICARDIAL EFFUSION 5 0.0002
786 HYPOMAGNESAEMIA 3 0.0002
787 THERAPY CESSATION 11 0.0002
788 INFECTION 31 0.0002
789 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
790 DYSARTHRIA 8 0.0002
791 DYSPNOEA EXERTIONAL 8 0.0002
792 CARDIAC FAILURE 17 0.0002
793 HYPOCALCAEMIA 4 0.0002
794 FEBRILE NEUTROPENIA 14 0.0002
795 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 15 0.0002
796 BLOOD URINE PRESENT 4 0.0002
797 VIRAL INFECTION 7 0.0002
798 LIP SWELLING 7 0.0002
799 FEELING JITTERY 4 0.0002
800 ANOSMIA 3 0.0002
801 LOCALISED INFECTION 5 0.0002
802 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
803 GASTROENTERITIS 3 0.0002
804 CEREBRAL INFARCTION 5 0.0002
805 HAEMATURIA 7 0.0002
806 NIGHTMARE 7 0.0002
807 COLON CANCER 3 0.0002
808 IMMUNODEFICIENCY 3 0.0002
809 HAEMORRHAGE 21 0.0002
810 PRESCRIBED UNDERDOSE 4 0.0002
811 PULMONARY EMBOLISM 19 0.0002
812 HAEMATOCHEZIA 11 0.0002
813 ECONOMIC PROBLEM 3 0.0002
814 DYSKINESIA 8 0.0002
815 THROMBOCYTOPENIA 22 0.0002
816 FLUID RETENTION 10 0.0002
817 DRUG DISPENSING ERROR 3 0.0002
818 INSURANCE ISSUE 3 0.0002
819 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
820 ASTHMA 22 0.0002
821 DELUSION 3 0.0002
822 LUNG INFECTION 3 0.0002
823 TREMOR 32 0.0002
824 COGNITIVE DISORDER 9 0.0002
825 C-REACTIVE PROTEIN INCREASED 7 0.0002
826 BASAL CELL CARCINOMA 3 0.0002
827 NERVOUS SYSTEM DISORDER 6 0.0002
828 UNDERDOSE 14 0.0002
829 PSORIASIS 25 0.0002
830 GASTRITIS 5 0.0002
831 ANXIETY 54 0.0002
832 DISEASE RECURRENCE 9 0.0002
833 PNEUMOTHORAX 3 0.0002
834 DEPRESSED MOOD 10 0.0002
835 HOSPITALISATION 29 0.0002
836 OBESITY 3 0.0002
837 IMPAIRED WORK ABILITY 4 0.0002
838 FEAR 5 0.0002
839 PAIN OF SKIN 5 0.0002
840 DISTURBANCE IN ATTENTION 10 0.0002
841 URTICARIA 31 0.0002
842 DEEP VEIN THROMBOSIS 12 0.0002
843 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
844 ADVERSE EVENT 17 0.0002
845 ILLNESS 19 0.0002
846 PRODUCT PRESCRIBING ISSUE 4 0.0002
847 DYSPEPSIA 18 0.0002
848 IMPAIRED HEALING 6 0.0002
849 INTENTIONAL PRODUCT USE ISSUE 16 0.0002
850 MULTIPLE FRACTURES 3 0.0002
851 PHOTOSENSITIVITY REACTION 3 0.0002
852 PLEURAL EFFUSION 11 0.0002
853 CYTOMEGALOVIRUS INFECTION 3 0.0002
854 URINARY RETENTION 6 0.0002
855 BLOOD UREA INCREASED 3 0.0002
856 PANCYTOPENIA 10 0.0002
857 RENAL IMPAIRMENT 15 0.0002
858 THERAPY NON-RESPONDER 8 0.0002
859 CHROMATURIA 4 0.0002
860 PAIN IN JAW 5 0.0002
861 CIRCULATORY COLLAPSE 3 0.0002
862 SCAR 3 0.0002
863 INJECTION SITE REACTION 12 0.0002
864 PARANOIA 3 0.0002
865 MUSCLE TWITCHING 4 0.0002
866 ABDOMINAL PAIN 40 0.0002
867 UNEVALUABLE EVENT 13 0.0002
868 RASH MACULAR 6 0.0002
869 EOSINOPHILIA 3 0.0002
870 COLD SWEAT 3 0.0002
871 LYMPHOCYTE COUNT DECREASED 3 0.0002
872 ACUTE MYOCARDIAL INFARCTION 5 0.0002
873 LYMPHADENOPATHY 6 0.0002
874 DRUG ERUPTION 3 0.0002
875 PRODUCT PRESCRIBING ERROR 4 0.0002
876 ROAD TRAFFIC ACCIDENT 7 0.0002
877 DEVICE ISSUE 15 0.0002
878 RESPIRATORY DISORDER 5 0.0002
879 DRUG EFFECT DECREASED 9 0.0002
880 ADVERSE DRUG REACTION 15 0.0002
881 APHASIA 5 0.0002
882 CRYING 6 0.0002
883 SEIZURE 19 0.0002
884 INJECTION SITE PRURITUS 11 0.0002
885 FEELING HOT 10 0.0002
886 DYSURIA 6 0.0002
887 INJECTION SITE BRUISING 13 0.0002
888 RECTAL HAEMORRHAGE 7 0.0002
889 SEPSIS 18 0.0002
890 HEPATIC STEATOSIS 3 0.0002
891 ANGIOEDEMA 7 0.0002
892 DRUG INTERACTION 25 0.0002
893 INCREASED APPETITE 3 0.0002
894 DEVICE MALFUNCTION 11 0.0002
895 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
896 METABOLIC ACIDOSIS 5 0.0002
897 PRODUCT SUBSTITUTION ISSUE 9 0.0002
898 POST PROCEDURAL COMPLICATION 3 0.0002
899 HAEMATOMA 4 0.0002
900 APPLICATION SITE ERYTHEMA 4 0.0002
901 ANHEDONIA 4 0.0002
902 BLOOD PRESSURE ABNORMAL 3 0.0002
903 BLOOD CHOLESTEROL INCREASED 7 0.0002
904 NEOPLASM MALIGNANT 10 0.0001
905 VOMITING 70 0.0001
906 BONE MARROW FAILURE 3 0.0001
907 MIGRAINE 14 0.0001
908 MULTIPLE SCLEROSIS 7 0.0001
909 BLOOD GLUCOSE DECREASED 7 0.0001
910 ABNORMAL DREAMS 4 0.0001
911 TOOTH LOSS 3 0.0001
912 MENTAL STATUS CHANGES 4 0.0001
913 PULMONARY HYPERTENSION 3 0.0001
914 KNEE ARTHROPLASTY 3 0.0001
915 HYPOXIA 5 0.0001
916 SKIN BURNING SENSATION 10 0.0001
917 DEVICE DISLOCATION 6 0.0001
918 SEPTIC SHOCK 6 0.0001
919 INJECTION SITE HAEMORRHAGE 11 0.0001
920 LIVER FUNCTION TEST ABNORMAL 4 0.0001
921 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
922 APPLICATION SITE PAIN 3 0.0001
923 ASCITES 4 0.0001
924 PYREXIA 47 0.0001
925 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
926 INJECTION SITE MASS 5 0.0001
927 TRANSAMINASES INCREASED 3 0.0001
928 ECZEMA 7 0.0001
929 IRRITABILITY 8 0.0001
930 APPLICATION SITE PRURITUS 3 0.0001
931 RHEUMATOID ARTHRITIS 15 0.0001
932 STOMATITIS 8 0.0001
933 MULTIPLE SCLEROSIS RELAPSE 9 0.0001
934 INJECTION SITE PAIN 40 0.0001
935 BONE DENSITY DECREASED 4 0.0001
936 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
937 HYPONATRAEMIA 7 0.0001
938 EMOTIONAL DISTRESS 15 0.0001
939 FIBROMYALGIA 3 0.0001
940 ENCEPHALOPATHY 3 0.0001
941 INJECTION SITE ERYTHEMA 15 0.0001
942 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
943 HAEMATEMESIS 3 0.0001
944 RENAL FAILURE ACUTE 5 0.0001
945 NEUTROPENIA 16 0.0001
946 PRODUCT USE IN UNAPPROVED INDICATION 29 0.0001
947 ERECTILE DYSFUNCTION 3 0.0001
948 MUCOSAL INFLAMMATION 3 0.0001
949 DERMATITIS ATOPIC 6 0.0001
950 TACHYCARDIA 10 0.0001
951 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
952 JAUNDICE 3 0.0001
953 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
954 RESPIRATORY FAILURE 8 0.0001
955 DEVICE DELIVERY SYSTEM ISSUE 3 0.0001
956 BREAST CANCER 10 0.0001
957 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
958 OXYGEN SATURATION DECREASED 6 0.0001
959 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
960 INFUSION RELATED REACTION 7 0.0001
961 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
962 LUNG DISORDER 5 0.0001
963 AGGRESSION 5 0.0001
964 INJURY 7 0.0001
965 PROSTATE CANCER 8 0.0001
966 DEVICE BREAKAGE 4 0.0001
967 NEUTROPHIL COUNT DECREASED 4 0.0001
968 LUNG NEOPLASM MALIGNANT 4 0.0001
969 DEVICE LEAKAGE 4 0.0001
970 MENTAL DISORDER 4 0.0001
971 DEVICE DIFFICULT TO USE 6 0.0001
972 LIVER DISORDER 4 0.0001
973 RESTLESSNESS 3 0.0001
974 AGITATION 6 0.0001
975 LEUKOPENIA 4 0.0001
976 ACNE 6 0.0001
977 INJECTION SITE SWELLING 6 0.0001
978 PANCREATITIS 4 0.0001
979 HEPATIC ENZYME INCREASED 5 0.0001
980 CARDIO-RESPIRATORY ARREST 3 0.0001
981 COLITIS ULCERATIVE 3 0.0001
982 SUICIDAL IDEATION 6 0.0001
983 RENAL CANCER 3 0.0001
984 ANAPHYLACTIC REACTION 3 0.0001
985 ILL-DEFINED DISORDER 3 0.0000
986 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
987 CARDIAC ARREST 4 0.0000
988 OVERDOSE 9 0.0000
989 TOXICITY TO VARIOUS AGENTS 5 0.0000